ASTRAZENECA AB et al v. TARO PHARMACEUTICALS U.S.A., INC.
| ASTRAZENECA AB and ASTRAZENECA PHARMACEUTICALS LP |
| TARO PHARMACEUTICALS U.S.A., INC. |
| 2:2022cv00892 |
| February 18, 2022 |
| US District Court for the District of New Jersey |
| Karen M Williams |
| Patent - Abbreviated New Drug Application(ANDA) |
| 15 U.S.C. ยง 1126 Patent Infringement |
| None |
Docket Report
RSS Track this Docket
This docket was last retrieved on February 18, 2022. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Filing 4 NOTICE of Appearance by CYNTHIA STENCEL BETZ on behalf of ASTRAZENECA AB, ASTRAZENECA PHARMACEUTICALS LP (BETZ, CYNTHIA) |
| Filing 3 Corporate Disclosure Statement by ASTRAZENECA PHARMACEUTICALS LP identifying AstraZeneca PLC as Corporate Parent.. (FLAHERTY, JOHN) |
| Filing 2 Corporate Disclosure Statement by ASTRAZENECA AB identifying AstraZeneca PLC as Corporate Parent.. (FLAHERTY, JOHN) |
| Filing 1 COMPLAINT against TARO PHARMACEUTICALS U.S.A., INC. ( Filing and Admin fee $ 402 receipt number ANJDC-13198875), filed by ASTRAZENECA AB, ASTRAZENECA PHARMACEUTICALS LP. (Attachments: #1 Exhibit A - U.S. Patent No. 10,300,065, #2 Civil Cover Sheet)(FLAHERTY, JOHN) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the New Jersey District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
